Scientists found that a combination of interferon alpha and anti-PD-1-based immunotherapy resulted in enhanced antitumor activity in unresectable hepatocellular carcinoma patients.
[Cancer Discovery]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
174014
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
